CytoMed Therapeutics
GDTC
#9843
Rank
โ‚ฌ24.5 M
Marketcap
2,12ย โ‚ฌ
Share price
-1.90%
Change (1 day)
12.94%
Change (1 year)

Annual Reports (20-F)

Latest form 20-F annual reports for CytoMed Therapeutics CIK: 0001873093
The 20-F is a 10-K equivalent for non-US companies, as a foreight company CytoMed Therapeutics only files 20-F reports

Thumbnail CytoMed Therapeutics 20-F Annual Report 2023

20-F Annual Report 2023

Language: English

View Annual Report (20-F)
Thumbnail CytoMed Therapeutics 20-F Annual Report 2022

20-F Annual Report 2022

Language: English

View Annual Report (20-F)